Document is current
Any future updates will be listed below
-
Authors
Chen, Liang
Liu, Yuanqing
Yu, Chenhao
Cao, Pei
Ma, Yiming
Geng, Yiran
Cai, Yu
Zhang, Yong
Liu, Jia
Li, Yang
Luan, Qingxian https://orcid.org/0000-0003-0209-8622
-
Funding
Funding for this research was provided by:
General Program of the National Natural Science Foundation of China (82370956)
National Key Research and Development Program of China (2023YFC2506300)
National Nature Science Foundation of China (82401105)
National Natural Science Foundation of China (32371533)
- License Information
-
More Information
Article History
Received: 6 December 2024
Accepted: 9 April 2025
First Online: 2 May 2025
Declarations
:
: Our iPSCs are derived from peripheral blood from one female healthy donor whose written consent was obtained in accordance with the guidelines of the Peking University Health Science Center Ethical Committee. The EallBio has confirmed that there was initial ethical approval for collection of human cells, and that the donors had signed informed consent. The animal experimental protocol was approved by the Biomedical Ethics Committee of Peking University (Title: Construction of Universal Non-immunogenic iPSC-MSCs and Evaluation of Their Effects on Periodontal Tissue Regeneration; Approval No.: PUIRB-LA2023075; Date: March 1, 2023). The work has been reported in line with the ARRIVE guidelines 2.0.
: Not applicable.
: The authors declare that they have no competing interests.
